SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability
A. D. Parisian, T. Koga, S. Miki, P. D. Johann, M. Kool, J. R. Crawford, F. Furnari
Abstract
Atypical teratoid rhabdoid tumors (ATRT) are challenging pediatric brain cancers which are predominantly associated with inactivation of the gene SMARCB1, a conserved subunit of the chromatin remodeling BAF complex, which has known contributions to developmental processes. To identify potential interactions between SMARCB1 loss and the process of neural development, we introduced an inducible SMARCB1 loss of function system into human induced pluripotent stem cells (iPSCs) which were subjected to either directed neuronal differentiation or differentiation into cerebral organoids. Using this system, we have identified substantial differences in the downstream effects of SMARCB1 loss depending on differentiation state and identified an interaction between SMARCB1 loss and neural differentiation pressure which causes a resistance to terminal differentiation and a defect in maintenance of a normal cell state. Our results provide insight into how SMARCB1 loss might interact with neural development in the process of ATRT tumorigenesis.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- BAF complexes cooperate with lineage-restricted transcription factors to establish cell-state-specific regulatory programs
Jiayou He, Carla Rios Arceo, … Jarno Drost·bioRxiv·Nov 11, 2026
- Diverse Mechanisms of SMARCB1 Inactivation and Genome Maintenance Defects in Ultra-Rare Malignant Rhabdoid Tumors
Elizabeth Rasmussen, Elena Mironova, … Raushan T. Kurmasheva·bioRxiv·Mar 2, 2026
- SMARCB1 loss creates patient-specific MYC topologies that drive malignant rhabdoid tumor growth
N. Q. Liu, I. Paassen, … J. Drost·bioRxiv·Nov 21, 2022
- The CoREST complex inhibitor, corin, leads to decreased tumor growth, increased cellular differentiation and extended lifespan in atypical teratoid rhabdoid tumor xenograft models
Anupa Geethadevi, Nikhil Vaidya, … Rhoda M. Alani·Neuro-OncologyPeer-reviewed·Jul 21, 2026
- Temporal Dynamics of SMARCA4 Loss Define Its Role in Myogenic Differentiation of Alveolar Rhabdomyosarcoma
Charity Conlin Jennings, Emma Lashyro, … Charles Keller·bioRxiv·Oct 21, 2026
- Differential chromatin response to retinoic acid in neuroblastoma according to type of ATRX mutation
Federica Lorenzi, Matthew Shipley, … Sally L. George·NeoplasiaPeer-reviewed·Dec 11, 2025